Published Studies
Nicotinamide Riboside Restores NAD+ in RYR1-Related Muscle Diseases: Preclinical Findings
Synopsis Mutations in the RYR1 gene cause a group of rare congenital muscle diseases (RYR1-RM) characterized by problems in calcium regulation within muscle cells, leading to muscle weakness and f...
Read moreSynopsis Alzheimer’s disease (AD) is a complex neurodegenerative disorder that urgently requires more effective, precisely targeted treatments. This study developed a biomimetic nanomedicine desig...
Read moreSynopsis Ganoderma lucidum (G. lucidum), also known as Reishi mushroom, has been valued in traditional Chinese medicine (TCM) for its anti-aging and kidney-protective properties. This study explor...
Read moreSynopsisNicotinamide riboside (NR) is a precursor to NAD⁺, a key molecule for cellular energy that declines with age. Aging can cause reduced brain and immune function, changes in blood, and greate...
Read moreNicotinamide Riboside Restores Vascular Health in ACTA2 Mutation: Preclinical Findings
Synopsis Mutations in ACTA2 affecting arginine 179 cause early-onset strokes due to moyamoya-like artery blockages. This study found that mutant smooth muscle cells (SMCs) remain immature, highly ...
Read moreNicotinamide Riboside Enhances Milk Production in Lactating Sows: Preclinical Findings
Synopsis Lactation insufficiency is a common challenge with unclear biological causes. This study examined how nicotinamide riboside (NR), a vitamin B3–derived NAD+ precursor, influences mammary g...
Read moreSynopsis Heat stress (HS) from rising global temperatures negatively affects male fertility, damaging the testes and reducing semen quality. This study examined how HS alters testicular NAD+ metab...
Read moreNicotinamide Riboside Enhances NK Cell Anti-Tumor Activity: Preclinical Findings
Synopsis Tumor-produced lactate weakens natural killer (NK) cells by causing lysine lactylation (Kla), disrupting NAD+ metabolism, and fragmenting mitochondria, which reduces cytotoxicity. Supplem...
Read moreNicotinamide Riboside Restores Mitochondrial Function in Aortic Aneurysms: Preclinical Findings
Synopsis Thoracic aortic aneurysms (TAA) are deadly vascular disorders linked to genetic mutations such as ACTA2R179H and TGFBR2G357W, which disrupt vascular smooth muscle cell (VSMC) function. Th...
Read moreNicotinamide Riboside and NMN Enhance CAR-T Cell Function in Aging: Preclinical Findings
Synopsis Chimeric antigen receptor (CAR) T cell therapy is a powerful cancer treatment, but its effectiveness declines with aging. This study found that CAR-T cells from aged female mice show mito...
Read moreNAD+ Deficiency Drives Kidney Dysfunction in Cockayne Syndrome: Preclinical Findings
SynopsisCockayne Syndrome (CS) is a premature aging disorder caused by mutations in the CSA and CSB genes, leading to problems like early aging, nerve damage, and kidney dysfunction. Cells from CS ...
Read moreNicotinamide Riboside Reduces Kidney Damage in Chronic Disease: Preclinical Findings
Synopsis Subclinical chronic kidney disease (sCKD) increases vulnerability to acute kidney injury (AKI). In a rat model where ischemia–reperfusion injury (IRI) was applied on top of sCKD, a dual t...
Read moreNicotinamide Riboside Protects the Intestinal Barrier From Heat Stress: Preclinical Findings
Synopsis Heat stress damages the intestinal epithelial barrier, allowing harmful substances to enter the body. This study tested whether nicotinamide riboside (NR), a NAD+ precursor, could protect...
Read moreSynopsis Brown adipose tissue (BAT) depends on NAD+ biosynthesis for healthy mitochondrial function and thermogenesis. Multi-omics analysis of BXD mouse strains showed that BAT NAD+ metabolism str...
Read moreSafety of Intravenous Nicotinamide Riboside Across Multiple Doses in Rats: Preclinical Findings
Synopsis This study evaluated the safety of repeated intravenous nicotinamide riboside (NR) at varying doses in Wistar rats. NR was well-tolerated at 150, 300, and 450 mg/kg, with no adverse effec...
Read moreNicotinamide Riboside Protects Against Doxorubicin Cardiotoxicity: Preclinical Findings
Synopsis In human iPSC-derived cardiomyocytes, nicotinamide riboside (NR) improved mitochondrial fusion, enhanced oxidative phosphorylation and ATP production, and upregulated ERRα, a key metaboli...
Read moreNicotinamide Riboside Prevents Oocyte Quality Loss in Maternal Diabetes: Preclinical Findings
Synopsis Diabetes reduces NAD+ levels in ovaries and oocytes, leading to poor oocyte quality, abnormal spindle formation, excess ROS, and impaired embryo development. In streptozotocin-induced dia...
Read moreMixed-Mode LC-MS Method Quantifies NAD+ and Its Metabolites: Preclinical Findings
Synopsis Measuring NAD+ and its metabolites is technically difficult because these molecules are highly polar and poorly retained by standard chromatography. This study developed a robust mixed-mo...
Read moreSynopsis Mitochondrial dysfunction and metabolic problems are major contributors to neurodegenerative diseases such as Parkinson’s (PD) and Alzheimer’s (AD). Research shows that combined metabolic...
Read moreSynopsis Bone cancer pain (BCP) disrupts mitochondrial function in spinal cord neurons, leading to damaged mitochondrial structure, reduced ATP production, and decreased membrane potential (MMP). ...
Read more